CTLA-4 is primarily expressed in Tregs and functionally exhausted T cells [57], and is also detectable on the surface of tumor-infiltrating NK cells, where its expression inhibits myeloid dendritic cell (mDC)-induced IFN-γ production [91]. The gene discussed is IFNG; the disease is neoplasm.